Cargando…

GCT-40. PROGNOSTIC FACTORS FOR PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)

BACKGROUND: Patients with relapsed CNS NGGCTs experience poor outcomes. Our aim to explore prognostic factors that may guide future clinical trials. METHODS: A review of clinical trials that included patients with relapsed CNS NGGCTs was performed. RESULTS: Seventy-four patients were identified; onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Arja, Mohammad H, Osorio, Diana S, Stanek, Joseph R, Finlay, Jonathan L, AbdelBaki, Mohamed S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Germ Cell Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715477/ http://dx.doi.org/10.1093/neuonc/noaa222.258

Ejemplares similares

GCT-29. DOES TUMOUR MARKER DECLINE PREDICT OUTCOME IN INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCTs)?
por: Conter, Cecile Faure, et al.
Publicado: (2020)

GCT-74. RETROSPECTIVE LITERATURE REVIEW OF CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCTs) IN PATIENTS WITH DOWN SYNDROME (DS)
por: Harris, Micah K, et al.
Publicado: (2020)

GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020)

GCT-66. FINAL REPORT OF THE PROSPECTIVE NEXT/CNS-GCT-4 CONSORTIUM TRIAL (GemPOx FOLLOWED BY MARROW-ABLATIVE CHEMOTHERAPY) IN PATIENTS WITH REFRACTORY/RECURRENT CNS GERM CELL TUMORS
por: Shatara, Margaret, et al.
Publicado: (2020)

GCT-10. Successful Salvage of Relapsed intracranial Non-Germinaoteous Germ Cell Tumors NGGCTs in a Child With Renal Insufficiency with Novel platinum-Free chemotherapy Regimen
por: Mobark, Nahla Ali, et al.
Publicado: (2022)

GCT-12. SIOP CNS GCT II: High Risk (HR) CNS Non-germinomatous Germ Cell Tumours (NGGCT) treated with Dose intensified PEI – final results
por: Calaminus, Gabriele, et al.
Publicado: (2022)

GCT-21. CENTRAL NERVOUS SYSTEM GERMINOMA - PONDERING THE NEXT STEPS
por: AbdelBaki, Mohamed S, et al.
Publicado: (2020)

GCT-22. PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT NON-GERMINOMATOUS CNS GERM CELL TUMORS
por: Tomiyama, Arata, et al.
Publicado: (2020)

GCT-28. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei, et al.
Publicado: (2020)

GCT-20. Multi-Institutional Analysis of Pediatric Relapsed/Refractory Central Nervous System Germ Cell Tumors
por: Nagabushan, Sumanth, et al.
Publicado: (2022)

GCT-25. INNOVATIVE, INTENSIVE IRRADIATION-AVOIDING/MINIMIZING CHEMOTHERAPY FOR HIGH-RISK PRIMARY CENTRAL NERVOUS SYSTEM (CNS) MIXED MALIGNANT GERM CELL TUMORS (HR-MMGCT): A PILOT STUDY AND PROPOSED MULTI-NATIONAL PROSPECTIVE TRIAL
por: Finlay, Jonathan L, et al.
Publicado: (2020)

GCT-46. MULTI-KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS AGAINST INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS
por: Uchida, Eita, et al.
Publicado: (2020)

GCT-42. CLINICAL CHARACTERISTICS OF LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) PATIENTS ENROLLED ON ACNS1123 WITH RELAPSE: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY
por: Dhall, Girish, et al.
Publicado: (2020)

GCT-63. STEREOTACTIC RADIOSURGERY FOR RESIDUAL LESIONS OF PINEAL NON-GERMINOMATOUS GERM CELL TUMORS AFTER CONVENTIONAL RADIOTHERAPY: A RETROSPECTIVE STUDY
por: Lai, Mingyao, et al.
Publicado: (2020)

GCT-08. Patients with Metastatic Central Nervous System Germinoma Involving the Basal Ganglia and Thalami, a Case Series
por: Abu-Arja, Mohammad, et al.
Publicado: (2022)

GCT-58. BRAZILIAN CENTRAL NERVOUS SYSTEM GERM CELL TUMOR CONSORTIUM PROTOCOL
por: Cappellano, Andréa M, et al.
Publicado: (2020)

GERM-01. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei
Publicado: (2021)

GCT-09. Transcriptome and methylome profiles of CNS germ cell tumors and their comparison with testicular counterpart
por: Takami, Hirokazu, et al.
Publicado: (2022)

GCT-19. Toward understanding of the pathogenesis of central nervous system germ cell tumors
por: Ichimura, Koichi, et al.
Publicado: (2022)

GCT-23. MULTI-INSTITUTIONAL ANALYSIS OF TREATMENT MODALITIES IN BASAL GANGLIA AND THALAMIC GERMINOMA
por: Graham, Richard T, et al.
Publicado: (2020)

GCT-33. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS
por: Murphy, Erin S, et al.
Publicado: (2020)

GCT-64. TREATMENT RESULTS IN CHILDREN WITH LOCALIZED CNS NGGCT
por: Vilesova, Irina, et al.
Publicado: (2020)

GCT-20. EVALUATION OF NEURORADIOLOGICAL RESPONSE TO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH LOCALISED GERMINOMA IN THE SIOP CNS GCT II TRIAL
por: Bison, Brigitte, et al.
Publicado: (2020)

GCT-49. EVALUATION OF THE PERIOPERATIVE AND POSTOPERATIVE COURSE OF SURGERY OF PINEAL GERMINOMA ACCORDING TO THE SIOP CNS GCT 96 TRIAL
por: Shabo, Ehab, et al.
Publicado: (2020)

GCT-14. The Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – A Single Institution Experience
por: Cantor, Evan, et al.
Publicado: (2022)

RARE-07. BONE MARROW ABLATIVE CHEMOTHERAPY ASSOCIATED WITH IMPROVED OUTCOMES AMONG PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS
por: Abu-Arja, Mohammad H, et al.
Publicado: (2023)

GCT-18. CLINICAL FEATURES OF GERM CELL TUMORS IN CHILDREN
por: Higa, Nayuta
Publicado: (2020)

GCT-62. DISSECTING INTRATUMORAL HETEROGENEITY OF CENTRAL NERVOUS SYSTEM GERM CELL TUMORS BY SINGLE-CELL RNA-SEQUENCING
por: Nakano, Tomoyuki, et al.
Publicado: (2020)

GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
por: Oller, Agustina, et al.
Publicado: (2020)

GCT-61. CORRELATION OF PATTERNS OF DISEASE RECURRENCE WITH RADIOTHERAPY TECHNIQUES AND DOSE IN INTRACRANIAL GERM CELL TUMOURS (icGCT): LESSONS FROM THE UK COHORT OF SIOP GCT96 STUDY
por: Ajithkumar, Thankamma, et al.
Publicado: (2020)

GCT-16. LONG-TERM CLINICAL OUTCOMES OF GERM CELL TUMORS
por: Matsuda, Kenichiro, et al.
Publicado: (2020)

GCT-14. SECOND-LOOK SURGERY FOR INTRACRANIAL GERM CELL TUMORS
por: Ogiwara, Hideki
Publicado: (2020)

GCT-13. KRAS MUTATION IN PEDIATRIC INTRACRANIAL GERM CELL TUMORS
por: Khaiman, Chusana, et al.
Publicado: (2022)

GERM-03. CLINICAL FEATURES AND OUTCOME OF CHILDREN WITH INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A POPULATION-BASED STUDY IN HONG KONG
por: P.Y. Liu, Anthony, et al.
Publicado: (2021)

GCT-31. DIAGNOSTIC CAPABILITY OF CSF-PLAP ON INTRACRANIAL GERM CELL TUMOR
por: Okamoto, Michinari, et al.
Publicado: (2020)

GCT-19. MODELING GERM CELL TUMORS WITH KIT MUTANT hiPSCs
por: Kuzuoka, Sakura, et al.
Publicado: (2020)

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS
por: Matsutani, Tomoo, et al.
Publicado: (2020)

GCT-60. DEVELOPMENT OF MICROBLEEDING AFTER PROTON THERAPY FOR PATIENTS WITH GERM CELL TUMOR
por: Kohzuki, Hidehiro, et al.
Publicado: (2020)

GCT-52. TRANSCRIPTOME OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR REVEALS ITS PATHOGENESIS AND CONTRASTS WITH TESTICULAR COUNTERPARTS IN INTEGRATED OMICS ANALYSIS
por: Takami, Hirokazu, et al.
Publicado: (2020)

GCT-15. INTEGRATED CLINICAL, HISTOPATHOLOGICAL, AND MOLECULAR DATA ANALYSIS OF 190 CENTRAL NERVOUS SYSTEM GERM CELL TUMORS FROM THE IGCT CONSORTIUM
por: Takami, Hirokazu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9nfn429jo1apfk4fknv11dstjq